thiazoles has been researched along with Hemangiosarcoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Azakami, D; Ishioka, K; Kinoshita, N; Maeda, M; Michishita, M; Morimatsu, M; Ochiai, K; Onozawa, E; Sadahira, T; Sakai, H; Sakaue, M; Tanaka, Y; Watanabe, M; Yamamoto, M | 1 |
Kow, K; Lyles, SE; Milner, RJ; Salute, ME | 1 |
Bleavins, MR; de la Iglesia, FA; Dethloff, LA; Duddy, SK; Gorospe, S; Gough, AW; Parker, RF; Rowse, PE | 1 |
Bleavins, MR; de la Iglesia, FA; Duddy, SK; Gorospe, SM | 1 |
Cornelis, JJ; DeMartino, L; Dinsart, C; Giese, NA; Raykov, Z; Rommelaere, J; Sozzani, S; Vecchi, A | 1 |
de la Iglesia, FA; Dethloff, LA; Gough, AW; Herman, JR; Masuda, H; McGuire, EJ; Parker, RF; Walsh, KM | 1 |
6 other study(ies) available for thiazoles and Hemangiosarcoma
Article | Year |
---|---|
Topics: Animals; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Dogs; HeLa Cells; Hemangiosarcoma; Humans; Mutation; Thiazoles | 2022 |
In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Dogs; Dose-Response Relationship, Drug; Hemangiosarcoma; In Situ Nick-End Labeling; In Vitro Techniques; Neoplasms, Vascular Tissue; Piperidines; Protein-Tyrosine Kinases; Pyridines; Skin Neoplasms; Thiazoles; Vascular Endothelial Growth Factor A | 2012 |
p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone.
Topics: Animals; Antioxidants; Chromans; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, p53; Hemangioma; Hemangiosarcoma; Immunohistochemistry; Male; Mice; Mice, Inbred Strains; Sequence Analysis, DNA; Thiazoles; Thiazolidinediones; Troglitazone; Vascular Neoplasms | 1999 |
Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
Topics: Animals; Carcinogens; Chromans; DNA, Neoplasm; Evolution, Molecular; Female; Genes, ras; Hemangiosarcoma; Male; Mice; Mice, Inbred Strains; Mutation; Polymerase Chain Reaction; Sequence Analysis; Thiazoles; Thiazolidinediones; Troglitazone; Vascular Neoplasms | 1999 |
Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.
Topics: Animals; Cell Line; Cell Separation; Cell Survival; Chemokine CXCL10; Chemokines, CXC; Coloring Agents; Endothelium; Flow Cytometry; Genetic Therapy; Genetic Vectors; Hemangiosarcoma; Liver; Mice; Mice, Inbred C57BL; Minute Virus of Mice; Neoplasm Metastasis; Parvovirus; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Time Factors; Transcription, Genetic; Transgenes; Tumor Cells, Cultured | 2002 |
Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone.
Topics: Adipose Tissue, Brown; Administration, Oral; Animals; Area Under Curve; Bone Marrow; Carcinogenicity Tests; Carcinogens; Carcinoma, Hepatocellular; Chromans; Dose-Response Relationship, Drug; Heart; Hemangiosarcoma; Hypoglycemic Agents; Liver; Liver Neoplasms; Longevity; Mice; Myocardium; Rats; Rats, Wistar; Species Specificity; Survival Analysis; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |